Matches in Wikidata for { <http://www.wikidata.org/entity/Q88012583> ?p ?o ?g. }
Showing items 1 to 60 of
60
with 100 items per page.
- Q88012583 description "article scientifique publié en 2018" @default.
- Q88012583 description "artículu científicu espublizáu en marzu de 2018" @default.
- Q88012583 description "im März 2018 veröffentlichter wissenschaftlicher Artikel" @default.
- Q88012583 description "scientific article published on 07 March 2018" @default.
- Q88012583 description "wetenschappelijk artikel" @default.
- Q88012583 description "наукова стаття, опублікована 7 березня 2018" @default.
- Q88012583 description "գիտական հոդված հրատարակված 2018 թվականի մարտի 7-ին" @default.
- Q88012583 name "Corrigendum to 'Effects of Delayed-release Dimethyl Fumarate (DMF) on Health-related Quality of Life in Patients With Relapsing-remitting Multiple Sclerosis: An Integrated Analysis of the Phase 3 DEFINE and CONFIRM Studies: [Clinical Therapeutics 36" @default.
- Q88012583 name "Corrigendum to 'Effects of Delayed-release Dimethyl Fumarate (DMF) on Health-related Quality of Life in Patients With Relapsing-remitting Multiple Sclerosis: An Integrated Analysis of the Phase 3 DEFINE and CONFIRM Studies: [Clinical Therapeutics 36" @default.
- Q88012583 type Item @default.
- Q88012583 label "Corrigendum to 'Effects of Delayed-release Dimethyl Fumarate (DMF) on Health-related Quality of Life in Patients With Relapsing-remitting Multiple Sclerosis: An Integrated Analysis of the Phase 3 DEFINE and CONFIRM Studies: [Clinical Therapeutics 36" @default.
- Q88012583 label "Corrigendum to 'Effects of Delayed-release Dimethyl Fumarate (DMF) on Health-related Quality of Life in Patients With Relapsing-remitting Multiple Sclerosis: An Integrated Analysis of the Phase 3 DEFINE and CONFIRM Studies: [Clinical Therapeutics 36" @default.
- Q88012583 prefLabel "Corrigendum to 'Effects of Delayed-release Dimethyl Fumarate (DMF) on Health-related Quality of Life in Patients With Relapsing-remitting Multiple Sclerosis: An Integrated Analysis of the Phase 3 DEFINE and CONFIRM Studies: [Clinical Therapeutics 36" @default.
- Q88012583 prefLabel "Corrigendum to 'Effects of Delayed-release Dimethyl Fumarate (DMF) on Health-related Quality of Life in Patients With Relapsing-remitting Multiple Sclerosis: An Integrated Analysis of the Phase 3 DEFINE and CONFIRM Studies: [Clinical Therapeutics 36" @default.
- Q88012583 P1433 Q88012583-A20ED3F6-6E40-493E-8BD1-2620C3A9AC1A @default.
- Q88012583 P1476 Q88012583-63C9F241-2B54-4538-B524-FBF49AEB84DE @default.
- Q88012583 P2093 Q88012583-13CC8095-3492-49F5-BD91-CF33C3C16F5A @default.
- Q88012583 P2093 Q88012583-496F5A14-4677-484B-994B-17CB3174DABB @default.
- Q88012583 P2093 Q88012583-5318619F-C912-4B7C-B848-62D4067BA7A2 @default.
- Q88012583 P2093 Q88012583-79B06CC7-597F-4ED1-9053-F18EF9795B19 @default.
- Q88012583 P2093 Q88012583-97DAE4A4-128B-4DD5-BB9A-50A44F2C97A8 @default.
- Q88012583 P2093 Q88012583-BEFEE718-C3FD-4423-A7FA-63D28EEB7C6A @default.
- Q88012583 P2093 Q88012583-DD50D2A1-98AD-4F9D-B512-4EC550BF245A @default.
- Q88012583 P2093 Q88012583-E11DFF3A-89ED-4CA4-9F2B-E59FE554CFBA @default.
- Q88012583 P2093 Q88012583-E9173C59-4727-471D-BE72-7AFF025430E0 @default.
- Q88012583 P2093 Q88012583-FD19EBCA-878C-440E-B160-EE338B86DEE1 @default.
- Q88012583 P304 Q88012583-0D8B046A-F1D5-4180-8478-211EE43AF090 @default.
- Q88012583 P31 Q88012583-4D329027-3EFF-4B60-BC2A-878CD8C6A480 @default.
- Q88012583 P31 Q88012583-BFE0ACA3-D923-4D98-BAE7-D2150E2D55AD @default.
- Q88012583 P356 Q88012583-44E4D964-606B-4757-AD46-54A374DF4C7D @default.
- Q88012583 P433 Q88012583-F63A0951-A225-41E0-8E3B-7F8CBD90B906 @default.
- Q88012583 P478 Q88012583-DD0049B7-FE55-4E64-932A-376F5103037A @default.
- Q88012583 P50 Q88012583-80293321-89D3-426D-B96C-574C4A2CA443 @default.
- Q88012583 P577 Q88012583-7F615C7C-84CE-475F-8F88-B5832F44C1FE @default.
- Q88012583 P698 Q88012583-D714F17D-44A7-4750-8F83-922BDB82B374 @default.
- Q88012583 P921 Q88012583-ADF50D2E-5D6E-4C1F-960E-58A826C491A8 @default.
- Q88012583 P356 J.CLINTHERA.2018.02.005 @default.
- Q88012583 P698 29523369 @default.
- Q88012583 P1433 Q15716601 @default.
- Q88012583 P1476 "Corrigendum to 'Effects of Delayed-release Dimethyl Fumarate (DMF) on Health-related Quality of Life in Patients With Relapsing-remitting Multiple Sclerosis: An Integrated Analysis of the Phase 3 DEFINE and CONFIRM Studies: [Clinical Therapeutics 36 (2014) 1958-1971]" @default.
- Q88012583 P2093 "Gavin Giovannoni" @default.
- Q88012583 P2093 "J Theodore Phillips" @default.
- Q88012583 P2093 "Jessica Kong" @default.
- Q88012583 P2093 "Ludwig Kappos" @default.
- Q88012583 P2093 "Macaulay Okwuokenye" @default.
- Q88012583 P2093 "Mariko Kita" @default.
- Q88012583 P2093 "Robert J Fox" @default.
- Q88012583 P2093 "Sarah I Sheikh" @default.
- Q88012583 P2093 "Sujata P Sarda" @default.
- Q88012583 P2093 "Vissia Viglietta" @default.
- Q88012583 P304 "812" @default.
- Q88012583 P31 Q13442814 @default.
- Q88012583 P31 Q1348305 @default.
- Q88012583 P356 "10.1016/J.CLINTHERA.2018.02.005" @default.
- Q88012583 P433 "5" @default.
- Q88012583 P478 "40" @default.
- Q88012583 P50 Q99630149 @default.
- Q88012583 P577 "2018-03-07T00:00:00Z" @default.
- Q88012583 P698 "29523369" @default.
- Q88012583 P921 Q18555066 @default.